The anti-catabolic effects of n-3 fatty acids
The reversal of catabolic processes remains a significant challenge, partly related to the complexity of such processes and our incomplete understanding of the mechanisms involved. The n-3 fatty acids may be able to attenuate catabolism. This review examines the potential sites of action for these f...
Gespeichert in:
| Veröffentlicht in: | Current opinion in clinical nutrition and metabolic care 1999-05, Vol.2 (3), p.219-226 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 226 |
|---|---|
| container_issue | 3 |
| container_start_page | 219 |
| container_title | Current opinion in clinical nutrition and metabolic care |
| container_volume | 2 |
| creator | Ross, James A Moses, Alastair G.W Fearon, Kenneth C.H |
| description | The reversal of catabolic processes remains a significant challenge, partly related to the complexity of such processes and our incomplete understanding of the mechanisms involved. The n-3 fatty acids may be able to attenuate catabolism. This review examines the potential sites of action for these fatty acids and the evidence that supports their anti-catabolic properties. |
| doi_str_mv | 10.1097/00075197-199905000-00005 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69988977</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69988977</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2715-4c5a64dbd938085059c4aebd8fe2fe0d0aa3e19901159575f54337db8c52fd203</originalsourceid><addsrcrecordid>eNp1kcFOwzAMQCMEYmPwC6gnbgGnaZrmiCYYSJO4jHOUJo5W6NbRpJr29wQ6EBcOVmzl2Y5eCMkY3DJQ8g4ApGBKUqaUApFKmgLECZmyQnJapsvTlPOSJ0TAhFyE8AbAcgX8nEwYFKLMBZsSulpjZraxodZEU3dtYzP0Hm0MWeezLeWZNzEeMmMbFy7JmTdtwKvjOSOvjw-r-RNdviye5_dLanPJBC2sMGXhaqd4BZUAoWxhsHaVx9wjODCGY3o6MCaUkMKLgnPp6sqK3Lsc-IzcjHN3ffcxYIh60wSLbWu22A1Bl0pVlZIygdUI2r4LoUevd32zMf1BM9BfqvSPKv2rSn-rSq3Xxx1DvUH3p3F0k4BiBPZdG7EP7-2wx16v0bRxrf_7Av4JdSZxWw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69988977</pqid></control><display><type>article</type><title>The anti-catabolic effects of n-3 fatty acids</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Ross, James A ; Moses, Alastair G.W ; Fearon, Kenneth C.H</creator><creatorcontrib>Ross, James A ; Moses, Alastair G.W ; Fearon, Kenneth C.H</creatorcontrib><description>The reversal of catabolic processes remains a significant challenge, partly related to the complexity of such processes and our incomplete understanding of the mechanisms involved. The n-3 fatty acids may be able to attenuate catabolism. This review examines the potential sites of action for these fatty acids and the evidence that supports their anti-catabolic properties.</description><identifier>ISSN: 1363-1950</identifier><identifier>EISSN: 1473-6519</identifier><identifier>DOI: 10.1097/00075197-199905000-00005</identifier><identifier>PMID: 10456251</identifier><language>eng</language><publisher>England: Lippincott Williams & Wilkins, Inc</publisher><subject>Animals ; Eicosanoids - biosynthesis ; Fatty Acids, Omega-3 - pharmacology ; Humans ; Membrane Fluidity - drug effects ; Metabolism - drug effects ; Signal Transduction - genetics</subject><ispartof>Current opinion in clinical nutrition and metabolic care, 1999-05, Vol.2 (3), p.219-226</ispartof><rights>1999 Lippincott Williams & Wilkins, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2715-4c5a64dbd938085059c4aebd8fe2fe0d0aa3e19901159575f54337db8c52fd203</citedby><cites>FETCH-LOGICAL-c2715-4c5a64dbd938085059c4aebd8fe2fe0d0aa3e19901159575f54337db8c52fd203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10456251$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ross, James A</creatorcontrib><creatorcontrib>Moses, Alastair G.W</creatorcontrib><creatorcontrib>Fearon, Kenneth C.H</creatorcontrib><title>The anti-catabolic effects of n-3 fatty acids</title><title>Current opinion in clinical nutrition and metabolic care</title><addtitle>Curr Opin Clin Nutr Metab Care</addtitle><description>The reversal of catabolic processes remains a significant challenge, partly related to the complexity of such processes and our incomplete understanding of the mechanisms involved. The n-3 fatty acids may be able to attenuate catabolism. This review examines the potential sites of action for these fatty acids and the evidence that supports their anti-catabolic properties.</description><subject>Animals</subject><subject>Eicosanoids - biosynthesis</subject><subject>Fatty Acids, Omega-3 - pharmacology</subject><subject>Humans</subject><subject>Membrane Fluidity - drug effects</subject><subject>Metabolism - drug effects</subject><subject>Signal Transduction - genetics</subject><issn>1363-1950</issn><issn>1473-6519</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kcFOwzAMQCMEYmPwC6gnbgGnaZrmiCYYSJO4jHOUJo5W6NbRpJr29wQ6EBcOVmzl2Y5eCMkY3DJQ8g4ApGBKUqaUApFKmgLECZmyQnJapsvTlPOSJ0TAhFyE8AbAcgX8nEwYFKLMBZsSulpjZraxodZEU3dtYzP0Hm0MWeezLeWZNzEeMmMbFy7JmTdtwKvjOSOvjw-r-RNdviye5_dLanPJBC2sMGXhaqd4BZUAoWxhsHaVx9wjODCGY3o6MCaUkMKLgnPp6sqK3Lsc-IzcjHN3ffcxYIh60wSLbWu22A1Bl0pVlZIygdUI2r4LoUevd32zMf1BM9BfqvSPKv2rSn-rSq3Xxx1DvUH3p3F0k4BiBPZdG7EP7-2wx16v0bRxrf_7Av4JdSZxWw</recordid><startdate>199905</startdate><enddate>199905</enddate><creator>Ross, James A</creator><creator>Moses, Alastair G.W</creator><creator>Fearon, Kenneth C.H</creator><general>Lippincott Williams & Wilkins, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199905</creationdate><title>The anti-catabolic effects of n-3 fatty acids</title><author>Ross, James A ; Moses, Alastair G.W ; Fearon, Kenneth C.H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2715-4c5a64dbd938085059c4aebd8fe2fe0d0aa3e19901159575f54337db8c52fd203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Eicosanoids - biosynthesis</topic><topic>Fatty Acids, Omega-3 - pharmacology</topic><topic>Humans</topic><topic>Membrane Fluidity - drug effects</topic><topic>Metabolism - drug effects</topic><topic>Signal Transduction - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ross, James A</creatorcontrib><creatorcontrib>Moses, Alastair G.W</creatorcontrib><creatorcontrib>Fearon, Kenneth C.H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current opinion in clinical nutrition and metabolic care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ross, James A</au><au>Moses, Alastair G.W</au><au>Fearon, Kenneth C.H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The anti-catabolic effects of n-3 fatty acids</atitle><jtitle>Current opinion in clinical nutrition and metabolic care</jtitle><addtitle>Curr Opin Clin Nutr Metab Care</addtitle><date>1999-05</date><risdate>1999</risdate><volume>2</volume><issue>3</issue><spage>219</spage><epage>226</epage><pages>219-226</pages><issn>1363-1950</issn><eissn>1473-6519</eissn><abstract>The reversal of catabolic processes remains a significant challenge, partly related to the complexity of such processes and our incomplete understanding of the mechanisms involved. The n-3 fatty acids may be able to attenuate catabolism. This review examines the potential sites of action for these fatty acids and the evidence that supports their anti-catabolic properties.</abstract><cop>England</cop><pub>Lippincott Williams & Wilkins, Inc</pub><pmid>10456251</pmid><doi>10.1097/00075197-199905000-00005</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1363-1950 |
| ispartof | Current opinion in clinical nutrition and metabolic care, 1999-05, Vol.2 (3), p.219-226 |
| issn | 1363-1950 1473-6519 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69988977 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Animals Eicosanoids - biosynthesis Fatty Acids, Omega-3 - pharmacology Humans Membrane Fluidity - drug effects Metabolism - drug effects Signal Transduction - genetics |
| title | The anti-catabolic effects of n-3 fatty acids |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A05%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20anti-catabolic%20effects%20of%20n-3%20fatty%20acids&rft.jtitle=Current%20opinion%20in%20clinical%20nutrition%20and%20metabolic%20care&rft.au=Ross,%20James%20A&rft.date=1999-05&rft.volume=2&rft.issue=3&rft.spage=219&rft.epage=226&rft.pages=219-226&rft.issn=1363-1950&rft.eissn=1473-6519&rft_id=info:doi/10.1097/00075197-199905000-00005&rft_dat=%3Cproquest_cross%3E69988977%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69988977&rft_id=info:pmid/10456251&rfr_iscdi=true |